Nothing Special   »   [go: up one dir, main page]

SE0300456D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0300456D0
SE0300456D0 SE0300456A SE0300456A SE0300456D0 SE 0300456 D0 SE0300456 D0 SE 0300456D0 SE 0300456 A SE0300456 A SE 0300456A SE 0300456 A SE0300456 A SE 0300456A SE 0300456 D0 SE0300456 D0 SE 0300456D0
Authority
SE
Sweden
Prior art keywords
novel compounds
variables
therapy
modulation
processes
Prior art date
Application number
SE0300456A
Other languages
Swedish (sv)
Inventor
Auten Pimm
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0300456A priority Critical patent/SE0300456D0/en
Publication of SE0300456D0 publication Critical patent/SE0300456D0/en
Priority to PCT/SE2004/000216 priority patent/WO2004074278A1/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to pyridine derivatives of formula (I) where the variables are defined in the specification.Processes for the preparation of these compounds together with pharmaceutical compositions containing them and their use in therapy in particular in the modulation of autoimmune disease is also described.
SE0300456A 2003-02-19 2003-02-19 Novel compounds SE0300456D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0300456A SE0300456D0 (en) 2003-02-19 2003-02-19 Novel compounds
PCT/SE2004/000216 WO2004074278A1 (en) 2003-02-19 2004-02-18 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300456A SE0300456D0 (en) 2003-02-19 2003-02-19 Novel compounds

Publications (1)

Publication Number Publication Date
SE0300456D0 true SE0300456D0 (en) 2003-02-19

Family

ID=20290456

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300456A SE0300456D0 (en) 2003-02-19 2003-02-19 Novel compounds

Country Status (2)

Country Link
SE (1) SE0300456D0 (en)
WO (1) WO2004074278A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4873352B2 (en) 2005-02-16 2012-02-08 シェーリング コーポレイション Piperazine substituted with a heterocyclic ring having CXCR3 antagonist activity
WO2006088840A1 (en) 2005-02-16 2006-08-24 Schering Corporation Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
JP2009530383A (en) 2006-03-21 2009-08-27 シェーリング コーポレイション Novel heterocyclic pyridine-substituted product having CXCR3 antagonistic activity
WO2008008453A1 (en) 2006-07-14 2008-01-17 Schering Corporation Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US8093246B2 (en) * 2006-12-14 2012-01-10 Lexicon Pharmaceuticals, Inc. O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer
JP2010527915A (en) * 2007-04-26 2010-08-19 アバロン ファーマシューティカルズ，インコーポレイテッド Multiple ring compounds and uses thereof
DE102008035552A1 (en) * 2008-07-30 2010-02-04 Bayer Schering Pharma Aktiengesellschaft Substituted pyridines and their use
HUE027598T2 (en) 2009-04-03 2016-10-28 Hoffmann La Roche Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
CN106220623A (en) 2009-11-06 2016-12-14 普莱希科公司 Compounds and methods for and indication thereof for kinases regulation
TWI619713B (en) 2010-04-21 2018-04-01 普雷辛肯公司 Compounds and methods for kinase modulation, and indications therefor
EA028821B9 (en) 2011-02-07 2018-10-31 Плексксикон, Инк. Compounds and methods for kinase modulation, and indications therefor
TW201348231A (en) * 2012-02-29 2013-12-01 Amgen Inc Heterobicyclic compounds
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
BR112015011148A8 (en) * 2012-11-16 2019-10-01 Merck Sharp & Dohme compound, pharmaceutical composition, and combination
SG11201605478XA (en) * 2014-01-06 2016-08-30 Rhizen Pharmaceuticals Sa Inhibitors of glutaminase
CN106674132B (en) * 2016-11-22 2019-04-26 上海书亚医药科技有限公司 A kind of preparation method and application of miazines herbicide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994456A (en) * 1989-03-01 1991-02-19 Nisshin Flour Milling Co., Ltd. Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
GB9514160D0 (en) * 1994-07-25 1995-09-13 Zeneca Ltd Aromatic compounds
FR2802533B1 (en) * 1999-12-17 2002-02-15 Sanofi Synthelabo PHENOXYPROPANOLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
AP1911A (en) * 2000-06-26 2008-10-30 Pfizer Prod Inc Pyrrolo[2,3-d]pyrimidine compounds.

Also Published As

Publication number Publication date
WO2004074278A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
SE0300456D0 (en) Novel compounds
ATE452129T1 (en) N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
BR0316350A (en) Diaminotriazoles useful as protein kinase inhibitors
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
SE0301700D0 (en) Novel compounds
IS2376B (en) Thienopyrimidinedione and their use in the development of self-hypersensitivity disease
ATE512147T1 (en) MACROCYCLIC AMINIOPYRIDYL BETA SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
DE502005008971D1 (en) SUBSTITUTED 1,4,8-TRIAZASPIROÄ4.5 DECAN-2-ON COMPOUNDS FOR THE TREATMENT OF FAT
ATE524181T1 (en) USE OF 1,4-BIS(3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
EA200601212A1 (en) PHOSPHODESTERASE INHIBITORS, OBTAINING AND THEIR THERAPEUTIC APPLICATION
CO5660287A2 (en) DERIVATIVES OF TETRAHYDROCARBAZOL AND ITS PHARMACEUTICAL USE
SE0302139D0 (en) Novel compounds
EA200700400A1 (en) DERIVATIVES N- (1H-INDOLIL) -1H-INDOL-2-CARBOXAMIDES, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
CY1109366T1 (en) Substituted Compounds 1,4,8-Triazazepiro [4.5] Decan-2-One
ATE482955T1 (en) AZABICYCLOOCTAN-3 DERIVATIVES AND THEIR USE
SE0300091D0 (en) Novel compounds
EA200401319A1 (en) NEW HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR USE IN MEDICINE
DE602004029355D1 (en) SULFOPYRROLDERIVATE
ATE523199T1 (en) PYRIDAZINE COMPOUNDS AND METHODS
EA200600992A1 (en) AMIDA TIAZOLIDINONA, AMIDA THIAZOLIDINCARBONIC ACID, METHODS FOR THEIR RECEPTION AND THEIR APPLICATION
SE0303280D0 (en) Novel compounds
ATE432936T1 (en) IMIDAZOTRIAZINE COMPOUNDS USED TO TREAT CANCER DISEASES
DE60119514D1 (en) AMID DERIVATIVES OF 2-AMINO-3-HYDROXY-4-TERT-LEUCYL-AMINO-5-PHENYL-PENTANIC ACID
PE20030236A1 (en) DERIVATIVES OF BENZIMIDAZOLE 1-ARIL-2-N, S- OR O-SUBSTITUTES, OBTAINING DRUGS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES